Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-06-28

FDA Approved: AMLODIPINE BESYLATE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva Pharmaceuticals' amlodipine besylate as a generic product in an Original Application for indications including hypertension and angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

ORIG AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)